» Articles » PMID: 35391738

Emergence of Resistant Mutants in Microfluidic Antibiotic Gradients

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Apr 8
PMID 35391738
Authors
Affiliations
Soon will be listed here.
Abstract

Spatiotemporal structures and heterogeneities are common in natural habitats, yet their role in the evolution of antibiotic resistance is still to be uncovered. We applied a microfluidic gradient generator device to study the emergence of resistant bacteria in spatial ciprofloxacin gradients. We observed biofilm formation in regions with sub-inhibitory concentrations of antibiotics, which quickly expanded into the high antibiotic regions. In the absence of an explicit structure of the habitat, this multicellular formation led to a spatial structure of the population with local competition and limited migration. Therefore, such structures can function as amplifiers of selection and aid the spread of beneficial mutations. We found that the physical environment itself induces stress-related mutations that later prove beneficial when cells are exposed to antibiotics. This shift in function suggests that exaptation occurs in such experimental scenarios. The above two processes pave the way for the subsequent emergence of highly resistant specific mutations.

Citing Articles

Deciphering population-level response under spatial drug heterogeneity on microhabitat structures.

Hu Z, Wood K, Wood K bioRxiv. 2025; .

PMID: 40027692 PMC: 11870443. DOI: 10.1101/2025.02.13.638200.


Linking spatial drug heterogeneity to microbial growth dynamics in theory and experiment.

Hu Z, Wu Y, Freire T, Gjini E, Wood K bioRxiv. 2024; .

PMID: 39605592 PMC: 11601811. DOI: 10.1101/2024.11.21.624783.


In Vitro Resistance-Predicting Studies and In Vitro Resistance-Related Parameters-A Hit-to-Lead Perspective.

Krajewska J, Tyski S, Laudy A Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204172 PMC: 11357384. DOI: 10.3390/ph17081068.


Microfluidic Ecology Unravels the Genetic and Ecological Drivers of T4r Bacteriophage Resistance in E. coli: Insights into Biofilm-Mediated Evolution.

Nagy K, Valappil S, Phan T, Li S, Der L, Morris R Res Sq. 2024; .

PMID: 38826273 PMC: 11142369. DOI: 10.21203/rs.3.rs-4356333/v1.


Microfluidics for adaptation of microorganisms to stress: design and application.

Zoheir A, Stolle C, Rabe K Appl Microbiol Biotechnol. 2024; 108(1):162.

PMID: 38252163 PMC: 10803453. DOI: 10.1007/s00253-024-13011-x.


References
1.
Wiegand I, Hilpert K, Hancock R . Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008; 3(2):163-75. DOI: 10.1038/nprot.2007.521. View

2.
Diver J, Wise R . Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin. J Antimicrob Chemother. 1986; 18 Suppl D:31-41. DOI: 10.1093/jac/18.supplement_d.31. View

3.
Kepler T, Perelson A . Drug concentration heterogeneity facilitates the evolution of drug resistance. Proc Natl Acad Sci U S A. 1998; 95(20):11514-9. PMC: 21672. DOI: 10.1073/pnas.95.20.11514. View

4.
Luis Martinez J, Fajardo A, Garmendia L, Hernandez A, Linares J, Martinez-Solano L . A global view of antibiotic resistance. FEMS Microbiol Rev. 2008; 33(1):44-65. DOI: 10.1111/j.1574-6976.2008.00142.x. View

5.
Weissborn A, Liu Q, RUMLEY M, Kennedy E . UTP: alpha-D-glucose-1-phosphate uridylyltransferase of Escherichia coli: isolation and DNA sequence of the galU gene and purification of the enzyme. J Bacteriol. 1994; 176(9):2611-8. PMC: 205399. DOI: 10.1128/jb.176.9.2611-2618.1994. View